Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma.
Yeo AT, Shah R, Aliazis K, Pal R, Xu T, Zhang P, Rawal S, Rose CM, Varn FS, Appleman VA, Yoon J, Varma H, Gygi SP, Verhaak RGW, Boussiotis VA, Charest A.
Yeo AT, et al. Among authors: gygi sp.
Cancer Immunol Res. 2023 May 3;11(5):629-645. doi: 10.1158/2326-6066.CIR-22-0655.
Cancer Immunol Res. 2023.
PMID: 36881002
Free PMC article.